Browse Drug Recalls

412 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 412 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 412 FDA drug recalls.

Clear
DateProductReasonClassFirm
Sep 23, 2026 Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufa... Failed dissolution specifications. Class II Apotex Corp.
Sep 17, 2026 Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marke... Failed Dissolution Specifications: below specification Class II Ajanta Pharma USA Inc
Sep 3, 2026 Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufact... Failed Dissolution Specifications Class II Inventia Healthcare Limited
Aug 31, 2026 Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx o... Failed dissolution specifications. Class III Supernus Pharmaceuticals, Inc.
Aug 26, 2026 Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile,... Failed Dissolution Specifications Class II Mylan Pharmaceuticals Inc
Aug 21, 2026 Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSM... Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled ... Class II Golden State Medical Supply Inc.
Aug 17, 2026 Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufacture... Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance c... Class II Mylan Pharmaceuticals Inc
Aug 13, 2026 Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx o... Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance c... Class II Apotex Corp.
Aug 4, 2026 Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manu... Failed Dissolution Specifications Class II Novartis Pharmaceuticals Corporation
Jul 24, 2026 Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx... Failed Dissolution Specifications Class II Mylan Pharmaceuticals Inc
Jul 8, 2026 Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bott... Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications Class II Ascend Laboratories, LLC
Jul 6, 2026 Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only... Failed Dissolution Specifications Class III Supernus Pharmaceuticals, Inc.
Jun 5, 2026 Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only,... Failed Dissolution Specifications Class II Inventia Healthcare Limited
Jun 1, 2026 Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bot... Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9... Class II Ascend Laboratories, LLC
May 29, 2026 GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets... Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was o... Class II Golden State Medical Supply Inc.
May 27, 2026 Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Di... Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolutio... Class II Lannett Company Inc.
May 5, 2026 Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bott... Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications Class II Ascend Laboratories, LLC
Apr 27, 2026 Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP,... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Mar 24, 2026 Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x ... Failed Dissolution Specifications Class II The Harvard Drug Group LLC
Mar 17, 2026 Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx ... Failed Dissolution Specifications Class II Viatris, Inc.
Feb 24, 2026 Isotretinoin Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs... Failed Dissolution Specifications Class II MYLAN PHARMACEUTICALS INC
Feb 13, 2026 Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Onl... Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification ... Class II AvKARE
Jan 29, 2026 Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets b... Failed Dissolution Specifications Class II Teva Pharmaceuticals USA, Inc
Jan 29, 2026 Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, R... Failed Dissolution Specifications Class II Teva Pharmaceuticals USA, Inc
Jan 29, 2026 Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (ND... Failed Dissolution Specifications Class II Teva Pharmaceuticals USA, Inc
Jan 29, 2026 Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (ND... Failed Dissolution Specifications Class II Teva Pharmaceuticals USA, Inc
Dec 31, 2025 Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per ... Out of specification for dissolution. Class II AvKARE
Oct 28, 2025 Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, ... Failed Dissolution Specifications: An out of specification results observed in dissolution test d... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Oct 28, 2025 Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, ... Failed Dissolution Specifications: An out of specification results observed in dissolution test d... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Oct 28, 2025 Lisdexamfetamine Dimesylate Capsules, 10 mg, CII, 100-count bottle, Rx only, ... Failed Dissolution Specifications: An out of specification results observed in dissolution test d... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Oct 28, 2025 Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, ... Failed Dissolution Specifications: An out of specification results observed in dissolution test d... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Oct 28, 2025 Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, ... Failed Dissolution Specifications: An out of specification results observed in dissolution test d... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Oct 28, 2025 Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, ... Failed Dissolution Specifications: An out of specification results observed in dissolution test d... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Oct 28, 2025 Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, ... Failed Dissolution Specifications: An out of specification results observed in dissolution test d... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Oct 20, 2025 NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx onl... Failed Dissolution Specifications Class II Golden State Medical Supply Inc.
Oct 10, 2025 Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottl... Failed Dissolution Specifications Class II Lannett Company Inc.
Sep 29, 2025 Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distribu... Failed dissolution specifications: Stability testing found that the lot did not meet dissolution ... Class II Acella Pharmaceuticals, LLC
Sep 19, 2025 Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-51... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Sep 19, 2025 Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 6787... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Sep 19, 2025 Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Sep 19, 2025 Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Sep 15, 2025 Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x... Failed Dissolution Specifications. Class II Amerisource Health Services LLC
Sep 3, 2025 Kit for the Preparation of Technetium Tc 99m Mertiatide, Rx Only, Manufacture... Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium T... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Aug 8, 2025 Theophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manuf... Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by ... Class II Glenmark Pharmaceuticals Inc., USA
Jul 21, 2025 Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton... Failed Dissolution Specifications: potential for delayed dissolution of the dose after administra... Class II Merck & Co. Inc
Jul 21, 2025 Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx... Failed Dissolution Specifications: low dissolution results Class II Ascend Laboratories, LLC
Jul 9, 2025 Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides... Failed Dissolution Specifications. Class II Strides Pharma, Inc.
Jun 24, 2025 Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100... Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the ... Class II Granules Pharmaceuticals Inc.
Jun 16, 2025 Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only,... Failed Dissolution Specifications: An out of specification results observed in dissolution test d... Class II SUN PHARMACEUTICAL INDUSTRIES INC
May 15, 2025 Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, 100 Tablets per bo... OOS results reported for the Dissolution (by UV) test. Class II Glenmark Pharmaceuticals Inc., USA

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.